Cargando…
Cancer Immunotherapy and the Immune Response in Follicular Lymphoma
Follicular lymphoma (FL) is the most frequent indolent lymphoma in the Western world and is characterized in almost all cases by the t(14;18) translocation that results in overexpression of BCL2, an anti-apoptotic protein. The entity includes a spectrum of subentities that differ from an indolent to...
Autores principales: | Stenner, Frank, Renner, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020779/ https://www.ncbi.nlm.nih.gov/pubmed/29974035 http://dx.doi.org/10.3389/fonc.2018.00219 |
Ejemplares similares
-
Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma
por: Renner, Christoph, et al.
Publicado: (2018) -
Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012) -
A rare case of follicular lymphoma of the bladder
por: DeSanto, Matthew, et al.
Publicado: (2023) -
Treatment selection for patients with relapsed or refractory follicular lymphoma
por: Skarbnik, Alan Z., et al.
Publicado: (2023) -
Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2020)